---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-075603"
form_type: "8-K"
ticker: "CLSDQ"
cik: "0001539029"
company_name: "Clearside Biomedical, Inc."
filed_at: "2024-06-20T23:59:59+00:00"
generated_at: "2026-06-01T03:22:36.210336+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Clearside Biomedical stockholders elect all three director nominees, approve say-on-pay, ratify E&Y

## Summary
- Directors Croarkin, Humphries, and Hutson elected with ~30M votes for each; no nominee withheld.
- Advisory vote on executive compensation approved: 22.8M for, 5.2M against, 6.6M abstentions.
- Ratification of Ernst & Young as independent auditor for FY2024 passed: 45.1M for, 4.9M against.
- Total shares present at meeting: 50.1M (67% of 74.7M outstanding).

## SEC filing metadata
- accession: 0000950170-24-075603
- form_type: 8-K
- ticker: CLSDQ
- cik: 0001539029
- company_name: Clearside Biomedical, Inc.
- filed_at: 2024-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1539029/000095017024075603/0000950170-24-075603-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1539029/000095017024075603/clsd-20240620.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-075603
- JSON: https://secwatch.observer/filing/0000950170-24-075603.json
- Plain text: https://secwatch.observer/filing/0000950170-24-075603.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.